Luis Carreño

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

Loreto Carmona, Juan J. Gómez‐Reino, Vicente Rodrı́guez-Valverde et al. · Arthritis & Rheumatism · 2005 · 655 citations

Medicine, Internal Medicine, Pharmacotherapy +17

A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects

Víctor M. Martínez‐Taboada, Vicente Rodrı́guez-Valverde, Luis Carreño et al. · Annals of the Rheumatic Diseases · 2007 · 313 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial

José María Álvaro‐Gracia, Juan Ángel Jover, Rosario García‐Vicuña et al. · Annals of the Rheumatic Diseases · 2016 · 263 citations

Medicine, Clinical Sciences, Internal Medicine +16

Association between anti–cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

Francisco Javier López‐Longo, Desamparados Oliver‐Miñarro, Inmaculada de la Torre et al. · Arthritis Care & Research · 2009 · 183 citations

Life Sciences, Immunology, Internal Medicine +17

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

Andrea Rubbert‐Roth, P. P. Tak, Cristiano A. F. Zerbini et al. · Lara D. Veeken · 2010 · 183 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16